Back HIV/AIDS

HIV / AIDS

June 5 Marks 35 Years Since First Report of AIDS

Sunday, June 5th marks the 35th anniversary of the first report of what would come to be known as AIDS. The past 3 decades have included remarkable progress in the field -- including highly effective antiretroviral therapy and a pill that can prevent HIV infection -- but much remains to be done to make these advances available to all who need them.

alt

17 Million People Worldwide Are Now Receiving HIV Treatment

The number of people with HIV receiving antiretroviral therapy (ART) worldwide has reached 17 million, although about the same number still do not have access to treatment and the decline in new infections has slowed, indicating the need to "reinvigorate" prevention efforts, according to the latest update from UNAIDS.

alt

Study Sheds New Light on What Happens During Acute HIV Infection

An individual's HIV viral load set-point is generally reached about a month after plasma viremia is first detectable, according to an analysis published in the May 18 online edition of the New England Journal of Medicine. The RV217 study, which included more than 100 people with acute HIV infection in East Africa and Thailand, found that signs and symptoms were uncommon during the earliest stages of infection, and what happens during this period influences later disease progression.

alt

At Least 6000 People Thought to Be on HIV PrEP in San Francisco

New numbers from the city's largest pre-exposure prophylaxis (PrEP) programs, along with estimates from primary providers and other smaller sources, suggest that more than 6000 people in San Francisco are receiving or have received Truvada for HIV prevention, most of them gay and bisexual men.

alt

Experimental HIV Vaccine to Enter Large Clinical Trial in South Africa

An investigational vaccine that showed promise in an earlier study will advance to a large-scale efficacy trial at 15 sites in South Africa, the U.S. National Institutes of Health (NIH) announced on May 18, marking HIV Vaccine Awareness Day. The new trial, HVTN 702, designed to determine if the vaccine is safe, well-tolerated, and effective at preventing HIV infection, is due to start this November, with results expected in 4 years.

alt

Denmark Shows Success of HIV Treatment as Prevention Among Gay Men

A study by researchers at the University of California at Los Angeles and Copenhagen University Hospital provides the first unambiguous evidence of a link between high rates of viral suppression among gay men and falling HIV incidence, or the proportion of men who catch HIV each year.

alt

HIV Prevalence and New Infections Highest Among Gay Men in Southern U.S.

The burden of HIV in the U.S. is disproportionately high for gay and bisexual men -- who account for about two-thirds of all newly diagnosed infections each year -- and HIV prevalence and new infections among men who have sex with men (MSM) is highest in states in the southeast, according to a new analysis published recently in the Journal of Medical and Internet Research -- Public Health and Surveillance.

alt